BL-8040 and Nelarabine for Relapsed or Refractory T-Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma
Clinical trial NCT02763384 · TERMINATED
Trial details
- NCT number
- NCT02763384
- Sponsor
- Washington University School of Medicine
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-02
- Primary completion
- 2022-02-11
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.